Cargando…

Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas

BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Laubert, Tilman, Habermann, Jens K, Hemmelmann, Claudia, Kleemann, Markus, Oevermann, Elisabeth, Bouchard, Ralf, Hildebrand, Philipp, Jungbluth, Thomas, Bürk, Conny, Esnaashari, Hamed, Schlöricke, Erik, Hoffmann, Martin, Ziegler, Andreas, Bruch, Hans-Peter, Roblick, Uwe J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349572/
https://www.ncbi.nlm.nih.gov/pubmed/22443372
http://dx.doi.org/10.1186/1471-230X-12-24
_version_ 1782232526581923840
author Laubert, Tilman
Habermann, Jens K
Hemmelmann, Claudia
Kleemann, Markus
Oevermann, Elisabeth
Bouchard, Ralf
Hildebrand, Philipp
Jungbluth, Thomas
Bürk, Conny
Esnaashari, Hamed
Schlöricke, Erik
Hoffmann, Martin
Ziegler, Andreas
Bruch, Hans-Peter
Roblick, Uwe J
author_facet Laubert, Tilman
Habermann, Jens K
Hemmelmann, Claudia
Kleemann, Markus
Oevermann, Elisabeth
Bouchard, Ralf
Hildebrand, Philipp
Jungbluth, Thomas
Bürk, Conny
Esnaashari, Hamed
Schlöricke, Erik
Hoffmann, Martin
Ziegler, Andreas
Bruch, Hans-Peter
Roblick, Uwe J
author_sort Laubert, Tilman
collection PubMed
description BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients. METHODS: 1,395 patients underwent surgery exclusively for colon cancer at the University of Lübeck between 01/1993 and 12/2008. The following exclusion criteria were applied: synchronous metastasis, R1-resection, prior/synchronous second carcinoma, age < 50 years, positive family history, inflammatory bowel disease, FAP, HNPCC, and follow-up < 5 years. The remaining 421 patients were divided into groups with (TM+, n = 75) or without (TM-, n = 346) the occurrence of metastasis throughout a 5-year follow-up. RESULTS: Five-year survival rates for TM + and TM- were 21% and 73%, respectively (p < 0.0001). Survival rates differed significantly for N0 vs. N2, grading 2 vs. 3, UICC-I vs. -II and UICC-I vs. -III (p < 0.05). Regression analysis revealed higher age upon diagnosis, increasing N- and increasing T-category to significantly impact on recurrence free survival while increasing N-and T-category were significant parameters for the risk to develop metastases within 5-years after surgery (HR 1.97 and 1.78; p < 0.0001). CONCLUSIONS: Besides a higher T-category, a positive N-stage independently implies a higher probability to develop distant metastases and correlates with poor survival. Our data thus show a prognostic relevance of lymphadenectomy which should therefore be retained until conclusive studies suggest the unimportance of lmyphadenectomy.
format Online
Article
Text
id pubmed-3349572
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33495722012-05-11 Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas Laubert, Tilman Habermann, Jens K Hemmelmann, Claudia Kleemann, Markus Oevermann, Elisabeth Bouchard, Ralf Hildebrand, Philipp Jungbluth, Thomas Bürk, Conny Esnaashari, Hamed Schlöricke, Erik Hoffmann, Martin Ziegler, Andreas Bruch, Hans-Peter Roblick, Uwe J BMC Gastroenterol Research Article BACKGROUND: Lymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients. METHODS: 1,395 patients underwent surgery exclusively for colon cancer at the University of Lübeck between 01/1993 and 12/2008. The following exclusion criteria were applied: synchronous metastasis, R1-resection, prior/synchronous second carcinoma, age < 50 years, positive family history, inflammatory bowel disease, FAP, HNPCC, and follow-up < 5 years. The remaining 421 patients were divided into groups with (TM+, n = 75) or without (TM-, n = 346) the occurrence of metastasis throughout a 5-year follow-up. RESULTS: Five-year survival rates for TM + and TM- were 21% and 73%, respectively (p < 0.0001). Survival rates differed significantly for N0 vs. N2, grading 2 vs. 3, UICC-I vs. -II and UICC-I vs. -III (p < 0.05). Regression analysis revealed higher age upon diagnosis, increasing N- and increasing T-category to significantly impact on recurrence free survival while increasing N-and T-category were significant parameters for the risk to develop metastases within 5-years after surgery (HR 1.97 and 1.78; p < 0.0001). CONCLUSIONS: Besides a higher T-category, a positive N-stage independently implies a higher probability to develop distant metastases and correlates with poor survival. Our data thus show a prognostic relevance of lymphadenectomy which should therefore be retained until conclusive studies suggest the unimportance of lmyphadenectomy. BioMed Central 2012-03-23 /pmc/articles/PMC3349572/ /pubmed/22443372 http://dx.doi.org/10.1186/1471-230X-12-24 Text en Copyright ©2012 Laubert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Laubert, Tilman
Habermann, Jens K
Hemmelmann, Claudia
Kleemann, Markus
Oevermann, Elisabeth
Bouchard, Ralf
Hildebrand, Philipp
Jungbluth, Thomas
Bürk, Conny
Esnaashari, Hamed
Schlöricke, Erik
Hoffmann, Martin
Ziegler, Andreas
Bruch, Hans-Peter
Roblick, Uwe J
Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title_full Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title_fullStr Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title_full_unstemmed Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title_short Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
title_sort metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349572/
https://www.ncbi.nlm.nih.gov/pubmed/22443372
http://dx.doi.org/10.1186/1471-230X-12-24
work_keys_str_mv AT lauberttilman metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT habermannjensk metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT hemmelmannclaudia metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT kleemannmarkus metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT oevermannelisabeth metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT bouchardralf metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT hildebrandphilipp metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT jungbluththomas metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT burkconny metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT esnaasharihamed metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT schlorickeerik metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT hoffmannmartin metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT zieglerandreas metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT bruchhanspeter metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas
AT roblickuwej metachronousmetastasisandsurvivalanalysisshowprognosticimportanceoflymphadenectomyforcoloncarcinomas